Breast cancer is the most commonly diagnosed cancer among women worldwide and represents a major public health concern due to ...

Case 1: Early-Stage Progesterone Receptor Positive Breast Cancer Patient: 45 yo premenopausal woman with stage II ER+/PR+ IDC. Result: Excellent response, no recurrence at 5 years.

Imagine a drug that halts cancer without side effects or risks. That future may be a bit nearer thanks to recent research led ...

Dr. Greg Vigna High progesterone receptor positivity linked to low-grade meningiomas, highlighting risks of Depo-Provera use Women who required a craniotomy for a progesterone receptor positive ...

Decision-making was influenced by patient values and did not vary by stage, race and ethnicity, or demographics.

Our study identifies progesterone receptors in the brain as one reason women are susceptible to migraines. Cyclical changes in progesterone levels during the menstrual cycle activate the receptor ...

Progesterone receptor (PR) is a key player in the pathophysiology of ER+/PR+ breast cancer. PR is an estrogen receptor dependent gene product meaning estrogen signaling regulates PR expression.